Wordt geladen...
Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match
Culture-adapted bone marrow mesenchymal stromal cells (MSCs) deploy paracrine anti-inflammatory and tissue regenerative functionalities that can be harnessed as a living cell pharmaceutical product. Independent of clinical indication, a near majority of human clinical trials administer MSC IV, often...
Bewaard in:
| Gepubliceerd in: | Blood Adv |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7218435/ https://ncbi.nlm.nih.gov/pubmed/32384543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001711 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|